|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A01K 67/027 | (2006.01) |
| C12N 15/90 | (2006.01) | ||
| C07K 14/705 | (2006.01) |
| (11) | Number of the document | 3434101 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18192264.2 |
| Date of filing the European patent application | 2014-09-23 | |
| (97) | Date of publication of the European application | 2019-01-30 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-16 |
| (46) | Date of publication of the claims translation | 2023-09-25 |
| (30) | Number | Date | Country code |
| 201361881261 P | 2013-09-23 | US |
| (72) |
MURPHY, Andrew J , US
THURSTON, Gavin , US
VARGHESE, Bindu , US
GURER, Cagen , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Gyvūnai, išskyrus žmogų, turintys humanizuoto signalą reguliuojančio baltymo geną |
| NON-HUMAN ANIMALS HAVING A HUMANIZED SIGNAL-REGULATORY PROTEIN GENE |
| Payment date | Validity (years) | Amount | |
| 2025-08-20 | 12 | 289.00 EUR |
| 2026-09-23 |